@FierceBiotech: ICYMI yesterday: Synergy soars on stellar constipation data, rekindling buyout chatter. Article | Follow @FierceBiotech
@JohnCFierce: BioMarin shines as dwarfism drug boosts growth in children. News | Follow @JohnCFierce
@DamianFierce: ICYMI: And hey $AGN's spending $2.1B on $KYTH and its chin-fat-reducing injection. Article | Follow @DamianFierce
> AstraZeneca ($AZN) and the French National Institute of Health and Medical Research (Inserm) have struck a deal to collaborate on new research related to diabetes and chronic kidney disease. Story
> Cynvenio Biosystems, which bills itself as a pioneer in LiquidBiopsy technology for the genomic analysis of tumor cells from whole blood, has garnered $25.5 million in a Series B. Release
Medical Device News
@FierceMedDev: FDA approves Roche's companion diagnostic for Pfizer's non-small cell lung cancer med. More from FierceDiagnostics | Follow @FierceMedDev
@VarunSaxena2: ICYMI: HeartWare, hit with its fifth Class 1 recall of 2015, will replace defective blood pump controllers. Report | Follow @VarunSaxena2
@EmilyWFierce: Shire, Sanofi and Bayer have the best public reps in pharma. FiercePharma report | Follow @EmilyWFierce
> After 2014 IPO and recent take-out rumor, medical laser player Lumenis to be acquired for $510M. Story
> Medtronic buys into Arsenal, gets option to purchase the post-surgical foam startup subsidiary. Article
Pharma News
@FiercePharma: Vets and pharma execs gather in DC to trade notes on pets in cancer research. FierceAnimalHealth story | Follow @FiercePharma
@CarlyHFierce: ICYMI: Valeant said to step up talks on potential $800M deal for Egypt's Amoun. Report | Follow @CarlyHFierce
> Novartis zeroes in on costs as blockbusters-to-be Cosentyx, Entresto rev up. Report
> Zoetis knocks off 165 NJ jobs in Ackman-forced cost squeeze. News
> Merck inks $5.9M settlement to wrap up AzaSite off-label investigation. Article
Vaccines News
> Merck, GSK, Sanofi and Pfizer will vie for crown in tight vaccines race by 2020: Report. More
> When it comes to a MERS vaccine, for Big Pharma, the money's not there yet. More
> Merck, Sanofi granted European Commission thumbs-up on Gardasil 9. Story
> Ebola vaccines left hanging as GSK, Merck, J&J scramble for trial volunteers. Article
> Move over, India--China can make WHO-approved vaccines, too. Report
CRO News
> Quintiles beefs up its risk-based monitoring tech. Report
> Veristat reaches into the Bay Area with new outpost. Item
> AMRI recruits PerkinElmer to build out a new R&D hub. Article
> GVK inks a deep biotech deal as it rebuilds its reputation. News
> PPD partners up for real-world outcomes research. Story
Pharma Manufacturing News
> Sun purges 18 Ranbaxy execs in integration move. Item
> Geri-Care buiding second plant in Mississippi. More
> Lonza building viral therapies plant in Texas. News
> Thermo Fisher putting $22M into new plant in Scotland. Article
> Ukraine drugmaker opens $40M plant in Kyiv. Report
Pharma Asia News
> A heavier China drives cardio, diabetes and healthcare reforms. Item
> India's Strides-Shasun merger hits roadblock over shareholding structure. More
> China FDA ahead for UCB's Neupro after PhIII Parkinson's results. Story
> Emerging markets, Advair generic the trick as India's Cipla eyes growth. Article
> Researchers say compound stops transmission of malaria parasite in mice. Report